Countries Europe
Sugemalimab Becomes First Anti-PD-L1 mAb Approved in Europe for First-Line Treatment of NSCLC
Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved in Europe for first-line treatment of both squamous and non...
July 29, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Accelerated Biosciences and Pluristyx Achieve Breakthrough in Creating Clinical Grade iPSC Lines Using Novel hTSC Starting Material
Accelerated Biosciences ("Accelerated Bio"), in partnership with Pluristyx, proudly announces the successful creation of clinical grade induced pluripotent...
July 15, 2024 | News
Aptamer Group and AstraZeneca Collaborate to Advance Targeted siRNA Delivery for Fibrotic Liver Cells
Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...
July 05, 2024 | News
Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria
Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...
July 04, 2024 | News
Celonic Group Expands Biologics Process Development with New Basel Facility
The Celonic Group, a “Pure Play” Biologics Contract Development Organization (CDMO) expands process development and optimization services in ...
June 19, 2024 | News
SciRhom GmbH Secures Approval for Clinical Trial Application of SR-878 in Austria
SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced the approval of a clinical trial a...
June 14, 2024 | News
Freudenberg Medical Invests Over $50 Million in New Hemoteq Production Facility in Germany
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry...
June 12, 2024 | News
Merck Opens Expanded Life Science Distribution Center in Germany
Expands facility by 25,000 square meters, nearly doubling size Adds new down filling capabilities and distribution space for Life Science customers Emp...
June 07, 2024 | News
Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
Thermo Fisher Scientific Announces IVDR Compliance for CytoScan Dx Assay and ChAS Dx Software, Enhancing Cytogenetic Testing in the EU
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied...
May 31, 2024 | News
ProBioGen and ModeX Therapeutics Partner to Accelerate Development of Multi-Specific COVID-19 Antibody
ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...
May 30, 2024 | News
Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies
The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...
May 01, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
